Hemicolectomy versus appendectomy alone for appendiceal neuroendocrine tumours between 1-2 cm in size-are we overtreating?
- PMID: 37859747
- PMCID: PMC10583003
- DOI: 10.21037/tcr-23-655
Hemicolectomy versus appendectomy alone for appendiceal neuroendocrine tumours between 1-2 cm in size-are we overtreating?
Keywords: Neuroendocrine tumours; appendix; surgery.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-655/coif). IJNK, MFR and RRG are recipients of the KiKa research grant paid to the institution especially as investment for the multicenter NET trial. IJNK reports that he receives funding from the Hartwig Foundation and EuroQoL, which are related to other research projects, not related in any manner to the topic of this manuscript. RRG reports that he receives the grant paid to the institution from Zonmw for the APAC trial, RCT on optimal treatment strategy for simple appendicitis in children (operative vs. non-operative) and the grant paid to the institution from LTC for the CAPP trial, Prospective cohort study on the optimal treatment strategy for complex appendicitis in the pediatric population. The other authors have no conflicts of interest to declare.
Comment on
-
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.Lancet Oncol. 2023 Feb;24(2):187-194. doi: 10.1016/S1470-2045(22)00750-1. Epub 2023 Jan 11. Lancet Oncol. 2023. PMID: 36640790
References
Publication types
LinkOut - more resources
Full Text Sources